title: Use of Plerixafor in patients that show failure of peripheral blood stem cell mobilization with G-CSF. Experience of three Dutch centers.
authors.affiliation: Department of Hematology, Erasmus MC, Rotterdam, Netherlands.
authors.forename: Y M
authors.initials: YM
authors.lastname: Bilgin
authors.forename: R R D
authors.initials: RR
authors.lastname: Gahar
authors.forename: O
authors.initials: O
authors.lastname: Visser
authors.forename: A
authors.initials: A
authors.lastname: Croockewit
authors.forename: G E
authors.initials: GE
authors.lastname: de Greef
mesh_terms: D019380:Anti-HIV Agents / Q000008:administration & dosage*; D001596:Benzylamines; D000080027:Cyclams; D005260:Female; D016179:Granulocyte Colony-Stimulating Factor / Q000008:administration & dosage; D019650:Hematopoietic Stem Cell Mobilization; D006571:Heterocyclic Compounds / Q000008:administration & dosage*; D006689:Hodgkin Disease / Q000097:blood / Q000628:therapy*; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000097:blood / Q000628:therapy*; D008297:Male; D009101:Multiple Myeloma / Q000097:blood / Q000628:therapy*; D036102:Peripheral Blood Stem Cell Transplantation; D014182:Transplantation, Autologous
chemical_list: D019380:Anti-HIV Agents; D001596:Benzylamines; D000080027:Cyclams; D006571:Heterocyclic Compounds; D016179:Granulocyte Colony-Stimulating Factor; C088327:plerixafor